Invention Grant
- Patent Title: CDK9 kinase inhibitors
- Patent Title (中): CDK9激酶抑制剂
-
Application No.: US14207841Application Date: 2014-03-13
-
Publication No.: US08969375B2Publication Date: 2015-03-03
- Inventor: Chunqiu Lai , Zhi-Fu Tao , Keith W. Woods , Thomas D. Penning , Andrew J. Souers , Anthony Mastracchio , Julie M. Miyashiro , Yunsong Tong
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie, Inc.
- Current Assignee: AbbVie, Inc.
- Current Assignee Address: US IL North Chicago
- Agent Changxia Sun
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/519 ; C07D519/00 ; C07D471/04 ; A61K31/437
Abstract:
Disclosed are compound of Formula (Ia), wherein R1A, R1, R2, R10, J, L, T, X, Y, and Z are as defined in the specification, and pharmaceutically acceptable salts thereof. The compounds may be used as agents in the treatment of diseases, including cancer. Also provided are pharmaceutical compositions, comprising one or more compounds of Formula (Ia).
Public/Granted literature
- US20140275153A1 CDK9 KINASE INHIBITORS Public/Granted day:2014-09-18
Information query
